Product Information
SPIRONOLACTONE 100 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1678 per EA under NDC 59651042801. Its NADAC has been published 193 times since Jan 25, 2023.
FDA first approved this application on Mar 6, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651042801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SPIRONOLACTONEApproval Type
Generic (ANDA)
FDA Application
ANDA202187FDA Approved
3/6/2014
TE Code
AB
On Market Since
12/13/2019
Pharmacological Classes
Price Statistics
The NADAC for SPIRONOLACTONE 100 MG TABLET has been published 193 times since Jan 25, 2023, and over the history we have for it it has declined 5.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1678 per EA |
|---|---|
| All-time high | $0.2545 (Jul 12, 2023) |
| All-time low | $0.1359 (Nov 20, 2024) |
| 52-week high | $0.1914 |
| 52-week low | $0.1678 |
| Median price | $0.1926 |
| Average price | $0.1919 |
| Largest weekly change | -29.7% (Nov 20, 2024) |
| Weeks tracked | 193 |
| Tracking since | Jan 25, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
SPIRONOLACTONE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aldosterone Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SPIRONOLACTONE 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SPIRONOLACTONE 100 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1678 per EA (NDC 59651042801), effective Sep 30, 2026.
How has the price of SPIRONOLACTONE 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for SPIRONOLACTONE 100 MG TABLET has declined 5.4%. It has been tracked across 193 weekly CMS publications since Jan 25, 2023.
What are the highest and lowest recorded NADAC prices for SPIRONOLACTONE 100 MG TABLET?
Since Jan 25, 2023, the NADAC for SPIRONOLACTONE 100 MG TABLET has ranged from a low of $0.1359 (Nov 20, 2024) to a high of $0.2545 (Jul 12, 2023), with a median of $0.1926 per EA.
Are there cheaper alternatives to SPIRONOLACTONE 100 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SPIRONOLACTONE 100 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SPIRONOLACTONE 100 MG TABLET?
SPIRONOLACTONE 100 MG TABLET (NDC 59651042801) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.